Gene · 285220
Papers448
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 448
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Weighted Single-Step Genomic Evaluation of Body Structural Traits for Early Selection of Growth Performance in Thai Swamp Buffalo. | Animals (Basel) | 2026 | 42450718 | PubTator, text mining | PubMed |
| Machine Learning-Based Prediction of Masaoka-Koga Stage and WHO Histological Risk Group in Thymic Epithelial Tumors Using Biomarker Combinations. | Diagnostics (Basel) | 2026 | 42449899 | PubTator, text mining | PubMed |
| Identification of telomere-related genes in the progression of colon adenocarcinoma: a bioinformatics analysis. | J Gastrointest Oncol | 2026 | 42434232 | PubTator, text mining | PubMed |
| Mathematical Modeling of Human Retinal Vascular Pattern Around the Foveal Avascular Zone. | Transl Vis Sci Technol | 2026 | 41769944 | PubTator, text mining | PubMed |
| Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm. | PLoS Comput Biol | 2026 | 41701761 | PubTator, text mining | PubMed |
| FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells. | Cell Commun Signal | 2026 | 41535944 | PubTator, text mining | PubMed |
| From thought to action: The organization of spinal projecting neurons. | Cell Rep | 2025 | 40818073 | PubTator, text mining | PubMed |
| Mef2c Controls Postnatal Callosal Axon Targeting by Regulating Sensitivity to Ephrin Repulsion. | J Neurosci | 2025 | 40228894 | PubTator, text mining | PubMed |
| Illuminating the dark kinome: utilizing multiplex peptide activity arrays to functionally annotate understudied kinases. | Cell Commun Signal | 2024 | 39415254 | PubTator, text mining | PubMed |
| [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation]. | Zhonghua Zhong Liu Za Zhi | 2024 | 39034804 | PubTator, text mining | PubMed |
| A pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets. | Front Oncol | 2024 | 38952552 | PubTator, text mining | PubMed |
| Runs of Homozygosity Detection and Selection Signature Analysis for Local Goat Breeds in Yunnan, China. | Genes (Basel) | 2024 | 38540373 | PubTator, text mining | PubMed |
| TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO. | J Exp Clin Cancer Res | 2024 | 38303029 | PubTator, text mining | PubMed |
| The TGF-β Family in Glioblastoma. | Int J Mol Sci | 2024 | 38256140 | PubTator, text mining | PubMed |
| Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer. | Breast Cancer Res Treat | 2024 | 38038766 | PubTator, text mining | PubMed |
| Long-lasting complete response to SHR-1701 plus famitinib in refractory advanced gallbladder cancer: A case report. | Hum Vaccin Immunother | 2023 | 38126815 | PubTator, text mining | PubMed |
| Receptor tyrosine kinases: biological functions and anticancer targeted therapy. | MedComm (2020) | 2023 | 38077251 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic Investigation of Rett Syndrome Reveals Increasing Complexity Trends from Induced Pluripotent Stem Cells to Neurons with Implications for Enriched Pathways. | ACS Omega | 2023 | 38027357 | PubTator, text mining | PubMed |
| Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China. | BMC Microbiol | 2023 | 37974063 | PubTator, text mining | PubMed |
| DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity. | bioRxiv | 2023 | 37961594 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/285220/papers